{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:50:31Z","timestamp":1785775831486,"version":"3.56.0"},"reference-count":67,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Exercise-induced pulmonary hypertension (EIPH) represents an abnormal pulmonary vascular response to increased blood flow during exercise, best characterized by a disproportionate rise in pulmonary arterial pressure relative to cardiac output. The shift from fixed pressure thresholds to flow-adjusted metrics, particularly the mPAP\u2013cardiac output slope, reflects a more physiologically sound approach and is now incorporated in the 2022 guidelines of the European Society of Cardiology\/European Respiratory Society as well as the World Symposium on PH. EIPH is a hemodynamic phenotype, not a standalone disease. Accumulating evidence demonstrates that EIPH has important diagnostic and prognostic implications. It is associated with reduced exercise capacity, increased risk of adverse cardiovascular outcomes, and reduced survival, even in patients with normal resting hemodynamics. Exercise hemodynamic abnormalities may also identify early or latent pulmonary vascular disease and early left heart dysfunction, particularly in at-risk populations such as systemic sclerosis, HFpEF, and genetic predisposition. In this review, we provide the current definition of EIPH as well as an overview of the prognostic implications and management of exercise-induced PH in cardiac and pulmonary diseases.<\/jats:p>","DOI":"10.3390\/jcdd13080366","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:51:23Z","timestamp":1785772283000},"page":"366","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exercise-Induced Pulmonary Hypertension: What Is New?"],"prefix":"10.3390","volume":"13","author":[{"given":"Ronald","family":"Zolty","sequence":"first","affiliation":[{"name":"Cardiology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1700578","DOI":"10.1183\/13993003.00578-2017","article-title":"An official European Respiratory Society statement: Pulmonary haemodynamics during exercise","volume":"50","author":"Kovacs","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.jacc.2020.10.007","article-title":"Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week","volume":"76","author":"Maron","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"L361","DOI":"10.1152\/ajplung.00098.2019","article-title":"Pulmonary Capillary Surface Area in Supine Exercising Humans: Demonstration of Vascular Recruitment","volume":"317","author":"Langleben","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1378\/chest.15-0125","article-title":"Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease","volume":"149","author":"Lau","year":"2016","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.chest.2018.01.022","article-title":"Exercise-Induced Pulmonary Hypertension: Translating Pathophysiological Concepts Into Clinical Practice","volume":"154","author":"Naeije","year":"2018","journal-title":"Chest"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.58.2.281","article-title":"Regulation of Stroke Volume During Submaximal and Maximal Upright Exercise in Normal Man","volume":"58","author":"Higginbotham","year":"1986","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"H923","DOI":"10.1152\/ajpheart.00720.2020","article-title":"Hemodynamic Function of the Right Ventricular-Pulmonary Vascular-Left Atrial Unit: Normal Responses to Exercise in Healthy Adults","volume":"320","author":"Wright","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmg.2014.12.003","article-title":"Pulmonary Hypertension in Valvular Disease: A Comprehensive Review on Pathophysiology to Therapy From the HAVEC Group","volume":"8","author":"Magne","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and Molecular Basis of Pulmonary Arterial Hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.03.540","article-title":"Management of Pulmonary Arterial hypertension","volume":"65","author":"McLaughlin","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1513\/AnnalsATS.201509-599FR","article-title":"The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension","volume":"13","author":"Thenappan","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary Hypertension Due to Left Heart Diseases","volume":"62","author":"Adir","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","unstructured":"Hatano, S., and Strasser, T. (1975). Primary Pulmonary Hypertension: Report on a WHO Meeting, Geneva, 15\u201317 October 1973, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/39094\/9241560444_eng.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"Galie","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"46","author":"Humbert","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, Classification and Diagnosis of Pulmonary Hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2103181","DOI":"10.1183\/13993003.03181-2021","article-title":"Diagnostic, Prognostic and Differential-Diagnostic Relevance of Pulmonary Haemodynamic Parameters During Exercise: A Systematic Review","volume":"60","author":"Zeder","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2400698","DOI":"10.1183\/13993003.00698-2024","article-title":"Prognostic Relevance of Exercise Pulmonary Hypertension: Results of the Multicentre PEX-NET Clinical Research Collaboration","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacc.2019.10.048","article-title":"Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort","volume":"75","author":"Ho","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e004750","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750","article-title":"Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure","volume":"11","author":"Eisman","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e023839","DOI":"10.1161\/JAHA.121.023839","article-title":"Influence of Upright Versus Supine Position on Resting and Exercise Hemodynamics in Patients Assessed for Pulmonary Hypertension","volume":"11","author":"Berlier","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_26","first-page":"e000088","article-title":"Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association","volume":"19","author":"Belkin","year":"2026","journal-title":"Circ. Heart Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1152\/japplphysiol.00372.2016","article-title":"Effects of Body Position on Exercise Capacity and Pulmonary Vascular Pressure-Flow Relationships","volume":"121","author":"Forton","year":"2016","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart Failure With Preserved Ejection Fraction: Everything the Clinician Needs to Know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart Failure With Preserved Ejection Fraction: A Review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ejhf.2821","article-title":"Disproportionate Exercise-Induced Pulmonary Hypertension in Relation to Cardiac Output in Heart Failure With Preserved Ejection Fraction: A Non-Invasive Echocardiographic Study","volume":"25","author":"Saito","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2400722","DOI":"10.1183\/13993003.00722-2024","article-title":"Pulmonary Gas Exchange in Relation to Exercise Pulmonary Hypertension in Patients With Heart Failure With Preserved Ejection Fraction","volume":"65","author":"Balmain","year":"2025","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week","volume":"76","author":"Guazzi","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/eurheartj\/ehy331","article-title":"Exercise Unmasks Distinct Pathophysiologic Features in Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease","volume":"39","author":"Gorter","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jchf.2023.05.032","article-title":"Comprehensive Investigation of Latent Pulmonary Vascular Disease: An Important Exercise for a Novel HFpEF Phenotype","volume":"11","author":"Oakland","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jchf.2023.08.030","article-title":"Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease","volume":"12","author":"Ishiyama","year":"2024","journal-title":"JACC Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-025-03633-5","article-title":"Association of Exercise-Induced Pulmonary Hypertension With Nailfold Capillary Density in Systemic Sclerosis: A Single-Center Retrospective Observational Study","volume":"27","author":"Kusaka","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2004229","DOI":"10.1183\/13993003.04229-2020","article-title":"Screening for Pulmonary Arterial Hypertension in Adults Carrying a BMPR2 Mutation","volume":"58","author":"Montani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary Arterial Hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.01.024","article-title":"Pulmonary Arterial Hypertension","volume":"51","author":"Chin","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.healun.2016.06.018","article-title":"Right Ventricular and Pulmonary Vascular Reserve in Asymptomatic BMPR2 Mutation Carriers","volume":"36","author":"Claessen","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2400442","DOI":"10.1183\/13993003.00442-2024","article-title":"Deep Phenotyping of Unaffected Carriers of Pathogenic BMPR2 Variants Screened for Pulmonary Arterial Hypertension","volume":"64","author":"Celant","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hinderhofer, K., Fischer, C., Pfarr, N., Szamalek-Hoegel, J., Lichtblau, M., Nagel, C., Egenlauf, B., Ehlken, N., and Gr\u00fcnig, E. (2014). Identification of a New Intronic BMPR2-mutation and Early Diagnosis of Heritable Pulmonary Arterial Hypertension in a Large Family With Mean Clinical Follow-Up of 12 Years. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091374"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12931-022-02238-9","article-title":"Abnormal Pulmonary Hemodynamics During Exercise Is Associated With Exercise Capacity in COPD","volume":"23","author":"Sassmann","year":"2022","journal-title":"Respir. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1183\/09031936.00085612","article-title":"Haemodynamic Responses to Exercise in Patients With COPD","volume":"41","author":"Hilde","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary Hypertension in Chronic Lung Diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.2147\/COPD.S161175","article-title":"Exercise Capacity in COPD Patients With Exercise-Induced Pulmonary Hypertension","volume":"13","author":"Hilde","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary Hypertension Associated With Lung Disease: New Insights into Pathomechanisms, Diagnosis, and Management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.healun.2012.02.029","article-title":"Mechanisms of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease: A Pathophysiologic Review","volume":"31","author":"Wrobel","year":"2012","journal-title":"J. Heart Lung Transplant."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1152\/japplphysiol.00877.2018","article-title":"Impaired Central Hemodynamics in Chronic Obstructive Pulmonary Disease During Submaximal Exercise","volume":"127","author":"Smith","year":"2019","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.chest.2024.04.025","article-title":"Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis","volume":"166","author":"Ang","year":"2024","journal-title":"Chest"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1159\/000550078","article-title":"Invasive Cardiopulmonary Exercise Testing Identifies Distinctive Hemodynamic Phenotypes in Patients With Interstitial Lung Disease and Exercise Intolerance","volume":"105","author":"Balakrishnan","year":"2025","journal-title":"Respiration"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.chest.2020.02.043","article-title":"Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease","volume":"158","author":"Oliveira","year":"2020","journal-title":"Chest"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1183\/09031936.00191014","article-title":"Pulmonary Vascular Response Patterns During Exercise in Interstitial Lung Disease","volume":"46","author":"Levarge","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.chest.2025.11.007","article-title":"Chronic Thromboembolic Pulmonary Disease With Exercise Pulmonary Hypertension: A Noninvasive Model to Predict Exercise Hemodynamics","volume":"169","year":"2026","journal-title":"Chest"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107580","DOI":"10.1016\/j.vph.2025.107580","article-title":"Exercise Pulmonary Hypertension in Chronic Thromboembolic Pulmonary Disease Without Resting Pulmonary Hypertension: A Systematic Review and Meta-Analysis","volume":"162","author":"Biondi","year":"2026","journal-title":"Vasc. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejim.2023.11.021","article-title":"Chronic Thromboembolic Pulmonary Disease: Association With Exercise-Induced Pulmonary Hypertension and Right Ventricle Adaptation Over Time","volume":"123","author":"Madonna","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1901982","DOI":"10.1183\/13993003.01982-2019","article-title":"Exercise Intolerance in Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Angioplasty","volume":"56","author":"Kikuchi","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Cal\u00e9, R., Ferreira, F., Martinho, M., Alegria, S., Repolho, D., Pereira, A.R., Luz, J., Lob\u00e3o, T., Ara\u00fajo, P., and Vitorino, S. (2026). Residual Physiological Abnormalities After Pulmonary Endarterectomy and Balloon Pulmonary Angioplasty in CTEPH. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0344192"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1090","DOI":"10.1161\/CIR.0000000000001197","article-title":"Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association","volume":"149","author":"Aggarwal","year":"2024","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCULATIONAHA.122.061828","article-title":"Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?","volume":"147","author":"Sarma","year":"2023","journal-title":"Circulation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"107921","DOI":"10.1016\/j.rmed.2024.107921","article-title":"Stroke Volume Augmentation Improves With PH-targeted Therapy in Patients With Exercise-Induced Pulmonary Hypertension","volume":"237","author":"Alisha","year":"2025","journal-title":"Respir. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"A960","DOI":"10.1016\/j.jacc.2026.02.2364","article-title":"Comparative Effectiveness of Riociguat Versus Sildenafil in Exercise-Induced Pulmonary Hypertension: A Single-Center Retrospective Study and Review of Pharmacological Therapies","volume":"87","author":"Kharawala","year":"2026","journal-title":"JACC"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","article-title":"Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial","volume":"9","author":"Burkhoff","year":"2021","journal-title":"JACC Heart Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cardfail.2025.06.009","article-title":"Oral Levosimendan for the Treatment of Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction: Rationale and Design of the LEVEL Trial: Rationale and Design of the LEVEL Trial","volume":"32","author":"Yaku","year":"2026","journal-title":"J. Card. Fail."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/366\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:16:23Z","timestamp":1785773783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcdd13080366"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13080366","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}